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Objective. Juvenile idiopathic arthritis (JIA) is a
childhood rheumatic disease of unknown etiology. Two
subgroups of JIA, i.e., oligoarticular and polyarticular,
are thought to have an autoimmune component, and
show a higher female:male ratio. Skewed X chromosome
inactivation (XCI) has previously been shown to be
associated with scleroderma and autoimmune thyroid-
itis, 2 autoimmune disorders occurring predominantly
in females. This study was undertaken to extend the
analysis to the pediatric age group and to determine the
XCI profiles of patients with JIA.
Methods. A polymorphic repeat in the androgen
receptor gene was genotyped to determine XCI status in
81 female patients with JIA (21 with polyarticular
disease and 60 with oligoarticular disease) and 211
healthy female controls. DNA obtained from venous
blood samples was used for this analysis.
Results. Informative data were obtained on 62 JIA
patients and 155 controls. Skewed XCI was observed in
14 patients (22.6%) and 11 controls (7.1%) (P  0.0036),
and extreme skewing was apparent in 8 patients (12.9%)
and 2 controls (1.3%) (P  0.0008).
Conclusion. Our findings in the present study
indicate that skewed XCI may be a risk factor for the
occurrence of autoimmune disorders, including JIA.
Juvenile idiopathic arthritis (JIA) is a broad term
for a group of diseases characterized by chronic inflam-
mation of 1 or more joints persisting longer than 6
weeks. It affects children before the age of 16, and its
etiology is unknown. The International League of Asso-
ciations for Rheumatology (ILAR) criteria set is the
most recent accepted classification scheme (1). It is
based on the number of affected joints and the presence
of systemic symptoms. According to the ILAR classifi-
cation, JIA is heterogeneous, with at least 6 subgroups:
1) systemic arthritis, 2) polyarthritis (rheumatoid factor
positive and rheumatoid factor negative), 3) oligoarthri-
tis (extended and persistent), 4) psoriatic arthritis, 5)
enthesis-related arthritis, and 6) undifferentiated arthri-
tis. Autoimmunity is particularly associated with the
polyarthritis and oligoarthritis subgroups, and girls are
more frequently affected than boys (female:male ratio
2–3:1) (2). Interestingly, an association between Turner’s
syndrome and juvenile arthritis has been reported (3).
It has long been recognized that hormone levels
and pregnancy-related fetal–maternal microchimerism
may influence the occurrence of autoimmunity (4,5).
Recently, our group and others observed that skewed X
chromosome inactivation (XCI) could be a novel pre-
disposition factor (6–8). Among these factors, XCI
could be considered a particularly attractive etiologic
candidate in JIA, since the onset of the disease is before
puberty, excluding the risks associated with hormone
levels and fetal microchimerism. In order to test the
hypothesis that XCI may play a role in the pathogenesis
of JIA, we determined the X chromosome inactivation
profiles of patients with JIA and control subjects.
PATIENTS AND METHODS
Patients. Eighty-one girls diagnosed as having JIA
according to the ILAR criteria and 211 healthy girls with no
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history of autoimmune disorders or cancer (control group;
mean  SD age 13  4 years) were included in the study. The
medical files of the parents were not available for analysis. The
mean  SD age of the JIA patients was 10  5 years, and the
mean age at the time of disease onset was 6  4 years.
Twenty-one of the JIA patients had polyarticular disease and
60 had oligoarticular disease. The following clinical data were
obtained on all patients: age, age at diagnosis, type of JIA,
disease duration, and treatment regimens. Informed consent
was obtained from all subjects (or legal guardians of subjects
who had not reached age of majority). The ethics committee of
Hacettepe University approved the study protocol.
X chromosome inactivation assay. The highly polymor-
phic CAG repeat on the first exon of the androgen receptor
gene was genotyped, as described elsewhere (6,8,9), to deter-
mine the XCI status of the patients and controls.
Statistical analysis. The significance of differences in
results between the JIA patients and the control subjects was
determined by Fisher’s exact test.
RESULTS
Findings on XCI status were informative in 62 of
the 81 JIA patients (76.5%) and in 155 of the 211
controls (73.5%). The individuals whose alleles could
not be distinguished adequately were not included in the
densitometric analysis and were categorized as having
noninformative results. Skewed XCI (80% skewing)
was observed in 14 of the 62 patients with informative
results (22.6%), and in 11 of the 155 controls with
informative results (7.1%) (P  0.0036). Extremely
skewed XCI ratios (90% skewing) were seen in 8 of
the 62 patients (12.9%), but in only 2 of the controls
(1.3%) (P  0.0008) (Table 1). Studies in large cohorts
have firmly established that extremely skewed XCI is
rare in the general population (10).
It has been reported that years after exposure to
an immunosuppressive agent, XCI ratios in feline hema-
topoietic cells may be skewed (11). We therefore inves-
tigated correlations between XCI ratios and treatment
regimens in the patients. All of the patients were receiv-
ing some treatment at the time of sample collection.
Fourteen were receiving nonsteroidal antiinflammatory
drugs (NSAIDs), 11 were receiving methotrexate
(MTX), 10 were receiving MTX plus NSAIDs, and 9
were receiving intraarticular corticosteroids plus
NSAIDs. The remaining 18 were receiving various com-
binations of these and other drugs. Clinical details on
the 62 patients are shown in Supplementary Table 1,
available on the Arthritis & Rheumatism Web site at
http://www3.interscience.wiley.com/journal/76509746/
home. Among the patients with skewed XCI, 7 (50%)
had received treatment with immunosuppressive agents
for 6–10 years, and 1 (7%) had received immunosup-
pressive treatment for 2 years. The remaining 6 had
received antiinflammatory treatment alone. Among the
patients with random patterns of XCI, 27 (56.3%) had
received immunosuppressive treatment for 2 years. At
any stage of their treatment, suspended leukopenia or
bone marrow ablation was not observed in any of the
patients. These results, along with previous observations
(6,8), indicate that it is unlikely that immunosuppressive
therapy caused skewed XCI in the patients.
DISCUSSION
Autoimmune disorders are complex and affect
5% of the world population (12). A diverse group of
autoimmune diseases, including rheumatoid arthritis
and JIA, affects females more frequently than males (2).
In this study, we observed skewed XCI patterns in
peripheral blood mononuclear cells of a significant
proportion of female subjects with JIA, with 22.6% in
the 80% skewing range (versus 7.1% of controls) and
12.9% in the 90% skewing range (versus 1.3% of
controls). These results support the hypothesis that loss
of XCI mosaicism in females may constitute a risk factor
for the development of JIA.
At present, the nature of the association between
skewed XCI and breakdown of self tolerance, as exem-
plified in this study on JIA and previous observations on
scleroderma (6) and autoimmune thyroiditis (7,8,13), is
not known. We propose that deleterious X-linked mu-
tations could influence the survival of cells that inacti-
vate a normal X chromosome and leave the mutant X
transcriptionally active. Since cells that inactivate the
mutant X would be immune to the deleterious effects of
the putative mutations, females could tolerate them by
losing their mosaic status for X-linked gene expression
(14,15). An interesting aspect of extremely skewed XCI
is that it does not lead to the breakdown of self tolerance
Table 1. Proportion of the juvenile idiopathic arthritis (JIA) patients






90 8 (12.9) 2 (1.3)
80–89 6 (9.7) 9 (5.8)
70–79 13 (21.0) 29 (18.7)
60–69 18 (29.0) 39 (25.2)
50–59 17 (27.4) 76 (49.0)
* Values are the number (%). For 80% skewing, P  0.0036 (odds
ratio 3.81 [95% confidence interval 1.65–8.83]); for 90% skewing,
P  0.0008 (odds ratio 11.33 [95% confidence interval 2.62–48.48]), by
Fisher’s 2-tailed exact test.
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in all females. This suggests that breakdown of self
tolerance may require 2 distinct events on the X chro-
mosome: first, a lethal mutation leading to loss of
mosaicism, and second, “heterozygosity” for the nonsyn-
onymous variants of the putative critical genes. To the
best of our knowledge, this is the first study that has
shown an association between skewed XCI and a pedi-
atric form of an autoimmune disease, i.e., JIA.
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